Document Classification

Section Type: METHODS

Text: The regimen as follows : (1) percutaneous estradiol gel (gel) containing 1. 5 mg of 17 beta-estradiol (E2) / d plus micronized progesterone (MP) 100 mg/d in group 1 (G1, E2 1. 5 + MP) ; (2) gel, 1. 5 mg E2/d plus medroxyprogesterone acetate (MPA), 2 mg/d in group 2 (G2, E2 1. 5 + MPA) ; (3) gel, 0. 75 mg E2/d plus MP, 100 mg/d in group 3 (G3, E2 0. 75 + MP) ; and (4) gel, 0. 75 mg E2/d plus MPA, 2 mg/d in group 4 (G4, E2 0. 75 + MPA).